Funch D - Search Results

1

Risk of Thyroid Cancer Associated with Use of Liraglutide and Other Antidiabetic Drugs in a US Commercially Insured Population.

Funch D, Mortimer K, Ziyadeh NJ, D Seeger J, Zhou L, Ng E, Ross D, Major-Pedersen A, Bosch-Traberg H, Gydesen H, Dore DD. Funch D, et al. Diabetes Metab Syndr Obes. 2021 Jun 10;14:2619-2629. doi: 10.2147/DMSO.S305496. eCollection 2021. Diabetes Metab Syndr Obes. 2021. PMID: 34140791 Free PMC article.

2

A prospective, claims-based assessment of the risk of pancreatitis and pancreatic cancer with liraglutide compared to other antidiabetic drugs.

Funch D, Gydesen H, Tornøe K, Major-Pedersen A, Chan KA. Funch D, et al. Diabetes Obes Metab. 2014 Mar;16(3):273-5. doi: 10.1111/dom.12230. Epub 2013 Nov 26. Diabetes Obes Metab. 2014. PMID: 24199745 Free PMC article.

3

Liraglutide use and evaluation of pancreatic outcomes in a US commercially insured population.

Funch D, Mortimer K, Ziyadeh NJ, Seeger JD, Li L, Norman H, Major-Pedersen A, Bosch-Traberg H, Gydesen H, Dore DD. Funch D, et al. Diabetes Obes Metab. 2019 Aug;21(8):1837-1848. doi: 10.1111/dom.13739. Epub 2019 May 24. Diabetes Obes Metab. 2019. PMID: 30945402 Free PMC article.

4

Is there an association between liraglutide use and female breast cancer in a real-world setting?

Funch D, Mortimer K, Li L, Norman H, Major-Pedersen A, Olsen AH, Kaltoft MS, Dore DD. Funch D, et al. Diabetes Metab Syndr Obes. 2018 Nov 22;11:791-806. doi: 10.2147/DMSO.S171503. eCollection 2018. Diabetes Metab Syndr Obes. 2018. PMID: 30538516 Free PMC article.

5

Performance of claims-based algorithms for identifying incident thyroid cancer in commercial health plan enrollees receiving antidiabetic drug therapies.

Funch D, Ross D, Gardstein BM, Norman HS, Sanders LA, Major-Pedersen A, Gydesen H, Dore DD. Funch D, et al. BMC Health Serv Res. 2017 May 5;17(1):330. doi: 10.1186/s12913-017-2259-3. BMC Health Serv Res. 2017. PMID: 28476125 Free PMC article.

6

Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients.

Funch DP, Walker AM, Schneider G, Ziyadeh NJ, Pescovitz MD. Funch DP, et al. Am J Transplant. 2005 Dec;5(12):2894-900. doi: 10.1111/j.1600-6143.2005.01115.x. Am J Transplant. 2005. PMID: 16303002 Free article. Clinical Trial.

7

Topical treatments with pimecrolimus, tacrolimus and medium- to high-potency corticosteroids, and risk of lymphoma.

Schneeweiss S, Doherty M, Zhu S, Funch D, Schlienger RG, Fernandez-Vidaurre C, Seeger JD. Schneeweiss S, et al. Among authors: funch d. Dermatology. 2009;219(1):7-21. doi: 10.1159/000209289. Epub 2009 Mar 17. Dermatology. 2009. PMID: 19293564

8

Algorithms for identification of Guillain-Barré Syndrome among adolescents in claims databases.

Funch D, Holick C, Velentgas P, Clifford R, Wahl PM, McMahill-Walraven C, Gladowski P, Platt R, Amato A, Chan KA. Funch D, et al. Vaccine. 2013 Apr 12;31(16):2075-9. doi: 10.1016/j.vaccine.2013.02.009. Epub 2013 Mar 6. Vaccine. 2013. PMID: 23474311

9

Methods and objectives of a large US multicenter case-control study of post-transplant lymphoproliferative disorder in renal transplant patients.

Funch DP, Brady J, Ko HH, Dreyer NA, Walker AM. Funch DP, et al. Recent Results Cancer Res. 2002;159:81-8. doi: 10.1007/978-3-642-56352-2_10. Recent Results Cancer Res. 2002. PMID: 11785847

10

Posttransplant lymphoproliferative disorder among renal transplant patients in relation to the use of mycophenolate mofetil.

Funch DP, Ko HH, Travasso J, Brady J, Kew CE 2nd, Nalesnik MA, Walker AM. Funch DP, et al. Transplantation. 2005 Nov 15;80(9):1174-80. doi: 10.1097/01.tp.0000169035.10572.c6. Transplantation. 2005. PMID: 16314782

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters